These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27881396)

  • 21. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
    Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
    Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
    J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
    Renner K; Hermann FJ; Schmidbauer K; Talke Y; Rodriguez Gomez M; Schiechl G; Schlossmann J; Brühl H; Anders HJ; Mack M
    Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
    You Y; Qin Y; Lin X; Yang F; Li J; Sooranna SR; Pinhu L
    BMC Nephrol; 2015 Aug; 16():148. PubMed ID: 26310926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.
    Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN
    Lupus; 2002; 11(7):411-8. PubMed ID: 12195781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of platelet-derived growth factor in lupus nephritis in MRL/MpJ-1pr/1pr mice.
    Entani C; Izumino K; Takata M; Futamura A; Nakagawa Y; Inoue H; Iida H
    Nephron; 1997; 77(1):100-4. PubMed ID: 9380223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.
    Zhao J; Wang H; Huang Y; Zhang H; Wang S; Gaskin F; Yang N; Fu SM
    Arthritis Rheumatol; 2015 Apr; 67(4):1036-44. PubMed ID: 25512114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice.
    Nakatani K; Yoshimoto S; Asai O; Sakan H; Terada M; Saito Y; Nose M; Iwano M; Konishi N
    Immun Inflamm Dis; 2013 Oct; 1(1):37-46. PubMed ID: 25400916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J; Sun M; Tian S
    Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
    Hamar P; Wang M; Godo M; Kokeny G; Rosivall L; Ouyang N; Heemann U
    Lupus; 2010 Feb; 19(2):175-81. PubMed ID: 19946036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.
    Menke J; Bork T; Kutska B; Byrne KT; Blanfeld M; Relle M; Kelley VR; Schwarting A
    Kidney Int; 2011 Feb; 79(4):452-63. PubMed ID: 20980973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
    Sasaki S; Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Tsuneyama K; Hirai Y; Takatsu K
    Mol Immunol; 2012 Jan; 49(4):611-20. PubMed ID: 22118968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
    Yang H; Xu A; Lv J; Liu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):821-5. PubMed ID: 22699062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of transforming growth factor-beta and tumor necrosis factor-alpha in the plasma and tissues of mice with lupus nephritis.
    Yamamoto K; Loskutoff DJ
    Lab Invest; 2000 Oct; 80(10):1561-70. PubMed ID: 11045573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.